StockData
Braveheart Bio, Inc. logo

Braveheart Bio, Inc. (BRVE) KPIs and segments

BRVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026
$18.78−0.71 (-3.64%)

Close on Nov 17, 2026Market cap $1.69BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Braveheart Bio's business

Coming soon

This tab will track the numbers specific to Braveheart Bio's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?